Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by Pjanimalon Aug 11, 2021 8:15pm
212 Views
Post# 33689654

RE:RE:RE:Record Second Quarter 2021 Results and Provides an Update

RE:RE:RE:Record Second Quarter 2021 Results and Provides an Update

My guess is to get the float down as low as possible, eliminate debt,  provide a good dividend with limited cash flow and sell when someone comes knocking with an offer they can't refuse.  Look at slide 15 in the apendix of the new brief.   First mention of valuation compared to recent acquisitions.  At 3.5 percent multiple to cash flow they are saying 3.25 per share. At fy 23 FCF of 320m looking at 4 bucks a share.  Still low, but they like to under promise.  


thoughts?

PJ

<< Previous
Bullboard Posts
Next >>